prazosin has been researched along with Psychotic Disorders in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alchin, DR | 1 |
Wadenberg, ML | 1 |
Hertel, P | 1 |
Fernholm, R | 1 |
Hygge Blakeman, K | 1 |
Ahlenius, S | 1 |
Svensson, TH | 1 |
2 other studies available for prazosin and Psychotic Disorders
Article | Year |
---|---|
'Vaping psychosis': Ultra-acute onset of severe, persisting and unusual psychotic symptoms following first-time cannabis vaping in a previously well individual.
Topics: Adult; Cannabis; Humans; Marijuana Abuse; Prazosin; Psychotic Disorders; Randomized Controlled Trial | 2020 |
Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Antipsychotic Agents; Avoidance Learning; Cataleps | 2000 |